Spitalul Clinic Filantropia
- Address
- lock Available on a paid plan
Spitalul Clinic Filantropia - Breast Cancer Research Center
Spitalul Clinic Filantropia is a distinguished clinical research facility specializing in advanced breast cancer therapeutics and women's health. The center demonstrates extensive expertise in conducting phase II and III clinical trials across multiple breast cancer subtypes, with particular emphasis on hormone receptor-positive, HER2-negative, and triple-negative breast cancer presentations.
- Early and metastatic breast cancer treatment optimization across all molecular subtypes
- Novel antibody-drug conjugates and targeted endocrine therapy investigations
- Adjuvant immunotherapy combinations for high-risk breast cancer populations
- Women's reproductive health including bacterial vaginosis and vulvovaginal candidiasis
The research program focuses on evaluating cutting-edge therapeutic agents including CDK4/6 inhibitors, selective estrogen receptor degraders, and immunotherapy combinations. The center actively participates in international multi-center trials examining both preoperative and adjuvant treatment strategies, contributing valuable data on progression-free survival and invasive breast cancer-free survival outcomes in diverse patient populations at high risk of recurrence.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 5 therapeutic areas and 15 of 58 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 57 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
- 1Merck Sharp & Dohme LLC4active
lock +9 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Merck Sharp & Dohme LLC5trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Spitalul Clinic Filantropia
lock Showing 1 of 21 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles. | Chemo Research S.L. | Phase III | Not Recruiting | Jul 2023 | Aug 2025 |
IMP list
lock Showing 1 of 58 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Paclitaxel | 5 | Unknown | 2022-08-31 | 2025-11-11 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.